Please Wait
Applying Filters...
menu
    • menu
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    1-propanamine, 3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 63Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rubicon Research Generic Amitriptyline HCL Receives Approval in the U.S
    Rubicon Research Generic Amitriptyline HCL Receives Approval in the U.S

    01 May 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215376

    FDA
    01 May 2023
    Share Share
    Centaur Pharma Generic Amitriptyline HCL Receives Apprival in the U.S
    Centaur Pharma Generic Amitriptyline HCL Receives Apprival in the U.S

    06 Jun 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216243

    FDA
    06 Jun 2022
    Share Share
    Health Canada Issues Recall of Apotex Inc's Elavil 10mg
    Health Canada Issues Recall of Apotex Inc's Elavil 10mg

    27 Jan 2022

    // HEALTH CANADA

    https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-apotex-incs-elavil-10mg-1643354827.pdf

    HEALTH CANADA
    27 Jan 2022
    Share Share
    Upsher-Smith Lab`s Generic Amitriptyline Hydrochloride Receives Approval in US
    Upsher-Smith Lab`s Generic Amitriptyline Hydrochloride Receives Approval in US

    10 Apr 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212654

    FDA
    10 Apr 2020
    Share Share
    Zydus Pharm’s Generic Amitriptyline Hydrochloride Receives Approval In US
    Zydus Pharm’s Generic Amitriptyline Hydrochloride Receives Approval In US

    11 Oct 2017

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210086

    FDA
    11 Oct 2017
    Share Share
    Enforcement Report - Week of August 30, 2017
    Enforcement Report - Week of August 30, 2017

    30 Aug 2017

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-30-2017-1504070345.pdf

    FDA
    30 Aug 2017
    Share Share